细胞外囊泡衍生circHIPK3:癌症的新型诊断生物标志物。

IF 2.5 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Yingying Zhu , Li Shen , Qiuyan Xia , Heyun Tao , Zhanguo Liu , Mengdie Wang , Xiaomin Zhang , Jun Zhang , Jian Lv
{"title":"细胞外囊泡衍生circHIPK3:癌症的新型诊断生物标志物。","authors":"Yingying Zhu ,&nbsp;Li Shen ,&nbsp;Qiuyan Xia ,&nbsp;Heyun Tao ,&nbsp;Zhanguo Liu ,&nbsp;Mengdie Wang ,&nbsp;Xiaomin Zhang ,&nbsp;Jun Zhang ,&nbsp;Jian Lv","doi":"10.1016/j.advms.2023.10.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>Lung cancer (LC) is a common malignancy worldwide. A great number of circular RNAs (circRNAs) have been identified that serve crucial roles in cancer development. Extracellular vesicles (EVs) and their contents have been shown to be biomarkers for the diagnosis and prognosis of LC. Thus, we intended to clarify the functional role of EVs-derived circRNA homology domain interacting protein kinase 3 (EVs-circ<em>HIPK3</em>) and its underlying mechanism of action.</p></div><div><h3>Material and methods</h3><p>Bioinformatics analysis was performed to validate the potential of partially circulating <em>HIPK3</em> in LC diagnosis. EVs were isolated by polyethylene glycol (PEG) precipitation from plasma of 52 LC patients and 30 healthy controls. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was employed to evaluate the expressions of candidate circRNAs (circ<em>HIPK3</em>) and microRNA-637 (miR-637, a target of circ<em>HIPK3</em>).</p></div><div><h3>Results</h3><p>Circ<em>HIPK3</em> is significantly up-regulated in LC, while miR-637 expression is significantly reduced (p ​&lt; ​0.05). Receiver operating characteristic (ROC) curve analysis, based on the expression of EVs-circ<em>HIPK3</em>, allowed us to distinguish LC from healthy controls (area under the curve, AUC 0.897).</p></div><div><h3>Conclusions</h3><p>Taken together, our study shows that EV-derived circ<em>HIPK3</em> can serve as a promising biomarker for LC patient diagnosis. However, the downstream mRNA of the circ<em>HIPK3</em>/miR-637 axis requires further exploration to enrich our understanding of circ<em>HIPK3</em>'s mechanism in LC.</p></div>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"68 2","pages":"Pages 426-432"},"PeriodicalIF":2.5000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Extracellular vesicle-derived circHIPK3: Novel diagnostic biomarker for lung cancer\",\"authors\":\"Yingying Zhu ,&nbsp;Li Shen ,&nbsp;Qiuyan Xia ,&nbsp;Heyun Tao ,&nbsp;Zhanguo Liu ,&nbsp;Mengdie Wang ,&nbsp;Xiaomin Zhang ,&nbsp;Jun Zhang ,&nbsp;Jian Lv\",\"doi\":\"10.1016/j.advms.2023.10.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><p>Lung cancer (LC) is a common malignancy worldwide. A great number of circular RNAs (circRNAs) have been identified that serve crucial roles in cancer development. Extracellular vesicles (EVs) and their contents have been shown to be biomarkers for the diagnosis and prognosis of LC. Thus, we intended to clarify the functional role of EVs-derived circRNA homology domain interacting protein kinase 3 (EVs-circ<em>HIPK3</em>) and its underlying mechanism of action.</p></div><div><h3>Material and methods</h3><p>Bioinformatics analysis was performed to validate the potential of partially circulating <em>HIPK3</em> in LC diagnosis. EVs were isolated by polyethylene glycol (PEG) precipitation from plasma of 52 LC patients and 30 healthy controls. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was employed to evaluate the expressions of candidate circRNAs (circ<em>HIPK3</em>) and microRNA-637 (miR-637, a target of circ<em>HIPK3</em>).</p></div><div><h3>Results</h3><p>Circ<em>HIPK3</em> is significantly up-regulated in LC, while miR-637 expression is significantly reduced (p ​&lt; ​0.05). Receiver operating characteristic (ROC) curve analysis, based on the expression of EVs-circ<em>HIPK3</em>, allowed us to distinguish LC from healthy controls (area under the curve, AUC 0.897).</p></div><div><h3>Conclusions</h3><p>Taken together, our study shows that EV-derived circ<em>HIPK3</em> can serve as a promising biomarker for LC patient diagnosis. However, the downstream mRNA of the circ<em>HIPK3</em>/miR-637 axis requires further exploration to enrich our understanding of circ<em>HIPK3</em>'s mechanism in LC.</p></div>\",\"PeriodicalId\":7347,\"journal\":{\"name\":\"Advances in medical sciences\",\"volume\":\"68 2\",\"pages\":\"Pages 426-432\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in medical sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1896112623000433\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in medical sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1896112623000433","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

目的:癌症是世界范围内常见的恶性肿瘤。大量的环状RNA(circRNA)已被鉴定为在癌症发展中发挥关键作用。细胞外小泡(EVs)及其内含物已被证明是LC诊断和预后的生物标志物。因此,我们旨在阐明EVs衍生的circRNA同源结构域相互作用蛋白激酶3(EVs-circHIPK3)的功能作用及其潜在作用机制。材料和方法:进行生物信息学分析,以验证部分循环HIPK3在LC诊断中的潜力。通过聚乙二醇(PEG)沉淀从52名LC患者和30名健康对照的血浆中分离EV。采用定量逆转录聚合酶链式反应(qRT-PCR)来评估候选circRNA(circHIPK3)和微小RNA-637(miR-637,circHIPK3的靶标)的表达。结果:CircHIPK3在LC中显著上调,而miR-637的表达显著降低(p​结论:总之,我们的研究表明,EV衍生的circHIPK3可以作为LC患者诊断的一种有前途的生物标志物。然而,circHIPK3/miR-637轴的下游mRNA需要进一步探索,以丰富我们对circHIPK3在LC中的机制的理解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Extracellular vesicle-derived circHIPK3: Novel diagnostic biomarker for lung cancer

Purpose

Lung cancer (LC) is a common malignancy worldwide. A great number of circular RNAs (circRNAs) have been identified that serve crucial roles in cancer development. Extracellular vesicles (EVs) and their contents have been shown to be biomarkers for the diagnosis and prognosis of LC. Thus, we intended to clarify the functional role of EVs-derived circRNA homology domain interacting protein kinase 3 (EVs-circHIPK3) and its underlying mechanism of action.

Material and methods

Bioinformatics analysis was performed to validate the potential of partially circulating HIPK3 in LC diagnosis. EVs were isolated by polyethylene glycol (PEG) precipitation from plasma of 52 LC patients and 30 healthy controls. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was employed to evaluate the expressions of candidate circRNAs (circHIPK3) and microRNA-637 (miR-637, a target of circHIPK3).

Results

CircHIPK3 is significantly up-regulated in LC, while miR-637 expression is significantly reduced (p ​< ​0.05). Receiver operating characteristic (ROC) curve analysis, based on the expression of EVs-circHIPK3, allowed us to distinguish LC from healthy controls (area under the curve, AUC 0.897).

Conclusions

Taken together, our study shows that EV-derived circHIPK3 can serve as a promising biomarker for LC patient diagnosis. However, the downstream mRNA of the circHIPK3/miR-637 axis requires further exploration to enrich our understanding of circHIPK3's mechanism in LC.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Advances in medical sciences
Advances in medical sciences 医学-医学:研究与实验
CiteScore
5.00
自引率
0.00%
发文量
53
审稿时长
25 days
期刊介绍: Advances in Medical Sciences is an international, peer-reviewed journal that welcomes original research articles and reviews on current advances in life sciences, preclinical and clinical medicine, and related disciplines. The Journal’s primary aim is to make every effort to contribute to progress in medical sciences. The strive is to bridge laboratory and clinical settings with cutting edge research findings and new developments. Advances in Medical Sciences publishes articles which bring novel insights into diagnostic and molecular imaging, offering essential prior knowledge for diagnosis and treatment indispensable in all areas of medical sciences. It also publishes articles on pathological sciences giving foundation knowledge on the overall study of human diseases. Through its publications Advances in Medical Sciences also stresses the importance of pharmaceutical sciences as a rapidly and ever expanding area of research on drug design, development, action and evaluation contributing significantly to a variety of scientific disciplines. The journal welcomes submissions from the following disciplines: General and internal medicine, Cancer research, Genetics, Endocrinology, Gastroenterology, Cardiology and Cardiovascular Medicine, Immunology and Allergy, Pathology and Forensic Medicine, Cell and molecular Biology, Haematology, Biochemistry, Clinical and Experimental Pathology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信